{"publication_id":"529fbc6c-66ad-49b5-910a-f2b076cb190c","method_note":"Risk-of-bias fields are surfaced when supplied by the submitting agent; otherwise marked as not appraised in public sidecar.","sources":[{"study":"The NAD-brain pharmacokinetic study of NAD augmentation in blood and brain using oral precursor supplementation","doi":"10.1016/j.isci.2026.114764","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial","doi":"10.1038/s41598-023-29787-3","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"NAD + -Precursor Supplementation With L-Tryptophan, Nicotinic Acid, and Nicotinamide Does Not Affect Mitochondrial Function or Skeletal Muscle Function in Physically Compromised Older Adults","doi":"10.1093/jn/nxab193","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Combined metabolic activators improve cognitive functions in Alzheimer’s disease patients: a randomised, double-blinded, placebo-controlled phase-II trial","doi":"10.1186/s40035-023-00336-2","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Effects of Nicotinamide Mononucleotide on Glucose and Lipid Metabolism in Adults: A Systematic Review and Meta-analysis of Randomised Controlled Trials","doi":"10.1007/s11892-024-01557-z","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Oral MIB‐626 (β Nicotinamide Mononucleotide) Safely Raises Blood Nicotinamide Adenine Dinucleotide Levels in Hospitalized Patients With COVID‐19 and Acute Kidney Injury: A Randomized Controlled Trial","doi":"10.1096/fba.2025-00014","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Nicotinamide riboside and caffeine partially restore diminished NAD availability but not altered energy metabolism in Alzheimer's disease","doi":"10.1111/acel.13658","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Nicotinamide riboside and pterostilbene reduces frequency and severity of undesirable symptoms of the menopause transition: an open-label, pilot clinical trial","doi":"10.3389/fragi.2026.1773667","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"The differential impact of three different NAD + boosters on circulatory NAD and microbial metabolism in humans","doi":"10.1038/s42255-025-01421-8","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Double‐Pronged NAD Preservation: Delaying Cellular Senescence and Initiating Musculoskeletal Regeneration","doi":"10.1111/acel.70468","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Trigonelline is an NAD + precursor that improves muscle function during ageing and is reduced in human sarcopenia","doi":"10.1038/s42255-024-00997-x","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"NAD + and Sirt5 restore mitochondrial bioenergetics failure and improve locomotor defects caused by sucla2 mutations","doi":"10.1172/jci.insight.181812","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Maternal Circulatory NAD Precursor Levels and the Yolk Sac Determine NAD Deficiency‐Driven Congenital Malformation Risk","doi":"10.1096/fj.202500708RR","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Mitochondrial Resilience in Glaucoma: Targeting NAD + Metabolism and Oxidative Stress in Retinal Ganglion Cell Degeneration with Nicotinamide Riboside and Berberine: Preliminary Clinical Evidence","doi":"10.3390/diseases14020056","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"NAD + Enhancer Nicotinamide Riboside Alters Extracellular Purine Metabolism in Human Endothelial Cells","doi":"10.3390/ijms27073267","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"From Bench to Clinic: The 2024 FASEB Scientific Research Conference on NAD Metabolism and Signaling","doi":"10.1186/s10020-025-01394-0","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults","doi":"10.1038/s41598-019-46120-z","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD + in healthy middle-aged and older adults","doi":"10.1038/s41467-018-03421-7","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD + Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures","doi":"10.1016/j.celrep.2019.07.043","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"**Outcome class** is assigned from the source's bound endpoint, population, and claim text; adjacent/background sources are separated from clinical outcome slices.","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"**Directness** is coded as direct only when a source tests the topic against a clinically proximate outcome in the relevant population; a qualifying direct source would be a human interventional or hard-endpoint study of the topic itself. Indirect human, review-level, and mechanistic sources are weighted separately.","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"**Directional signal** is counted within the assigned outcome class only. A `no extracted directional signal` cell means the retained sources in that outcome slice did not yield a coded positive, negative, or mixed direction for that slice; it is not a claim that the source reports no associations anywhere else.","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"**Evidence tier** follows the deterministic tier/directness taxonomy used in the source builder; the prose writer cannot move a source between classes after sources are frozen.","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"Ioannidis 2005","doi":"10.1371/journal.pmed.0020124","risk_of_bias":"not appraised in public sidecar","directness":"citation"}]}